Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2025-12-30 @ 2:10 PM
Study NCT ID:
NCT01146535
Status:
COMPLETED
Last Update Posted:
2013-08-21
First Post:
2010-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment
Sponsor:
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
QCR09025
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |